H. Lundbeck A/S (OTCMKTS:HLUYY – Get Free Report)’s stock price crossed below its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $22.00 and traded as low as $22.00. H. Lundbeck A/S shares last traded at $22.00, with a volume of 7,500 shares.
H. Lundbeck A/S Price Performance
The company has a debt-to-equity ratio of 0.32, a current ratio of 1.15 and a quick ratio of 0.71. The firm has a market capitalization of $21.91 billion, a price-to-earnings ratio of 25.00 and a beta of 0.68. The business’s fifty day simple moving average is $22.00 and its 200 day simple moving average is $22.00.
H. Lundbeck A/S Company Profile
H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat depression/schizophrenia.
Read More
- Five stocks we like better than H. Lundbeck A/S
- How to Calculate Return on Investment (ROI)
- TJX Companies Can Hit New Highs; Double-Digit Upside to Follow
- Ride Out The Recession With These Dividend Kings
- A Hidden Gem Retailer With 20% Upside
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Zoom Stock’s Earnings Volatility Picked Up a Lot of Buyers
Receive News & Ratings for H. Lundbeck A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. Lundbeck A/S and related companies with MarketBeat.com's FREE daily email newsletter.
